|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 103, 1123-1128, Copyright © 1993 by American College of Chest Physicians
ARTICLES |
PL Paggiaro, B Vagaggini, FL Dente, E Bacci, L Bancalari, M Carrara, A Di Franco, D Giannini and C Giuntini
Second Institute of Clinical Medicine, University of Pisa, Italy.
Long-term change in nonspecific and specific bronchial hyperresponsiveness was studied in 16 subjects with asthma induced by toluene diisocyanate (TDI). A significant positive correlation between months of follow-up and provocative dose inducing a 20 percent fall in FEV1 (PD20FEV1) methacholine was observed in 5 of 16 subjects. In 4 of these 5 subjects, a PD20FEV1 > 1 mg of methacholine was observed 30 to 48 months after the end of TDI exposure. In most subjects, nonspecific bronchial hyperresponsiveness did not change. Nine of 16 subjects became nonresponsive to TDI at follow-up examination, but only 3 of these showed a significant increase in PD20FEV1 methacholine. Seven subjects were still responsive to TDI. Recovery from TDI-induced asthma can occur and only after long-term work cessation. Nonspecific bronchial hyperresponsiveness to methacholine can persist even in the absence of bronchial hyperresponsiveness to TDI, suggesting permanent chronic damage to mechanisms controlling airway tone.
This article has been cited by other articles:
![]() |
P J Nicholson, P Cullinan, A J Newman Taylor, P S Burge, and C Boyle Evidence based guidelines for the prevention, identification, and management of occupational asthma Occup. Environ. Med., May 1, 2005; 62(5): 290 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Vandenplas, K. Toren, and P.D. Blanc Health and socioeconomic impact of work-related asthma Eur. Respir. J., October 1, 2003; 22(4): 689 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. PIIRILA, H. NORDMAN, H. M. KESKINEN, R. LUUKKONEN, S.-P. SALO, T. O. TUOMI, and M. TUPPURAINEN Long-term Follow-up of Hexamethylene Diisocyanate-, Diphenylmethane Diisocyanate-, and Toluene Diisocyanate-induced Asthma Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 516 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giannini, A. Di Franco, E. Bacci, F. L. Dente, M. Taccola, B. Vagaggini, and P. Paggiaro The Protective Effect of Salbutamol Inhaled Using Different Devices on Methacholine Bronchoconstriction Chest, May 1, 2000; 117(5): 1319 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. SCHEERENS, T. L. BUCKLEY, T. L. MUIS, J. GARSSEN, J. DORMANS, F. P. NIJKAMP, and H. VAN LOVEREN Long-term Topical Exposure to Toluene Diisocyanate in Mice Leads to Antibody Production and In Vivo Airway Hyperresponsiveness Three Hours after Intranasal Challenge Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1074 - 1080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |